Eventide Asset Management - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q2 2022$32,813,000
-1.0%
1,790,144
-13.1%
0.70%
+35.3%
Q1 2022$33,142,000
+73.9%
2,061,044
+51.4%
0.52%
+113.6%
Q4 2021$19,055,000
-25.3%
1,361,0440.0%0.24%
-27.7%
Q3 2021$25,492,000
+73.7%
1,361,044
+93.3%
0.34%
+70.6%
Q2 2021$14,678,000
-67.9%
704,000
-56.5%
0.20%
-70.9%
Q1 2021$45,729,000
+32.1%
1,617,573
+52.6%
0.68%
+27.7%
Q4 2020$34,620,000
+182.5%
1,060,000
+165.0%
0.53%
+121.2%
Q3 2020$12,256,000400,0000.24%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders